KY Included In Abbott Settlement
{Frankfort, Kentucky}...Attorney General Jack Conway announced Monday that, as part of a legal settlement with Illinois-based Abbott Laboratories, Kentucky will receive $4.6 million. Abbott agreed to pay $1.5 billion to the federal government and several states to resolve allegations that it promoted the anti-seizure drug Depakote for uses that were not approved by the Food and Drug Administration. U.S. Attorney Timothy Heaphy said people at top levels in Abbott carried out a strategy of systematically marketing the drug for purposes other than what federal regulators had allowed. Depakote is an anti-seizure and mood-stabilizing drug prescribed for bipolar disorder. Abbott admitted it had marketed the drug for unapproved uses, including treatment of schizophrenia, agitated dementia and autism.
